References
- National Institutes of Health. National Heart, Lung, and Blood Institute, Available at: http://www.nhlbi.nih.gov/guidelines/asthma/index.htm National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. August 2007. NIH Publication No. 07-4051
- Expert Panel Report 3 (EPR-3). Guidelines for the diagnosis and management of asthma: summary report 2007. J Allergy Clin Immunol 2007; 120: S94–S138
- Sont J K, Willems L NA, Bel E H, van Krieken J HJM, Vendenbroucke J P, Sterk P J, et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 1999; 159: 1043–1051
- Green R H, Brightling C E, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet 2002; 360: 1715–1721
- Silkoff P E, Carlson M, Bourke T, Katial R, Ogren E, Szefler S J. The aerocrine exhaled nitric oxide monitoring system niox is cleared by the US food and drug administration for monitoring therapy in asthma. J Allergy Clin Immunol 2004; 114(5)1241–1256
- American Thoracic Society. ATS/ERS recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children—2005. Am J Respir Crit Care Med 2005; 171: 912–930
- Jones S L, Herbison P, Cowan J O, et al. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J 2002; 20(3)601–608
- Silkoff P E, McClean P, Spino M, Erlich L, Slutsky A S, Zamel N. Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest 2001; 119(5)1322–1328
- Szefler S J, Phillips B R, Martinez F D, Chinchilli V M, Lemanske R F, Strunk R C, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005; 115: 233–242
- Martin R J, Szefler S J, King T S, Kraft M, Boushey H A, Chinchilli V M, et al. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol 2007; 119: 73–80
- Smith A D, Cowan J O, Brassett K P, Herbison G P, Taylor D R. Use of exhaled nitric oxide 423 measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352(21)2163–2173
- Busse W W, Mitchell H. Addressing issues of asthma in inner city children. J Alergy Clin Immunol 2007; 119: 43–49
- Jones C A, Clement L T, Morphew T, Kwong K YC, Hanley-Lopez J, Lifson F, et al. Achieving and maintaining asthma control in an urban pediatric disease management program: the Breathmobile Program. J Allergy Clin Immunol 2007; 119: 1445–1453
- Zefler S J, Mitchell H, Sorkness C A, Gergen P J, O'Connor G T, Morgan W J, et al. Adding exhaled nitric oxide to guideline-based asthma treatment in inner-city adolescents and young adults: a randomized controlled trial. Lancet 2008, in press
- Mauad T, Bel E H, Sterk P J. Asthma therapy and airway remodeling. J Allergy Clin Immunol 2007; 120: 997–1009
- Holgate S T. Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007; 120: 1233–1244
- Chen W, Hershey G K. Signal transducer and activator of transcription signals in allergic disease. J Allergy Clin Immunol 2007; 119: 529–541
- Schmidt-Weber C B, Akdis M, Akdis C A. Th17 cells in the big picture of immunology. J Allergy Clin Immunol 2007; 120: 247–254